BERACTANT
UNII S866O45PIG

Substance Identification & Data

This profile provides standardized clinical and technical data for Beractant, uniquely identified by the FDA Unique Ingredient Identifier (UNII) S866O45PIG.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 108778-82-1 and the RxNorm Concept ID (RxCUI) 46967. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

S866O45PIG

CAS Registry Number

108778-82-1

RxNorm Concept ID

46967

Detailed Substance Profile

Preferred Name

BERACTANT

Official standardized name for this substance within the FDA UNII nomenclature system.

Molecular Formula

S866O45PIG

The specific atomic composition represented as a molecular structure string.

NCI Thesaurus

C81354

National Cancer Institute reference terminology for clinical and research data.

USAN ID

Y-80

Identifier assigned by the United States Adopted Names Council.

Substance Type

mixture

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Beractant. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

BERACTANT

Common Names & Synonyms

BERACTANT [MART.]

BERACTANT [MI]

BERACTANT [ORANGE BOOK]

BERACTANT [USAN]

BERACTANT [VANDF]

BERACTANT [WHO-DD]

COMPOSITION PROVIDES 25 MG/ML OF PHOSPHOLIPIDS (INCLUDING 11.0-15.5 MG/ML OF DISATURATED PHOSPHATIDYLCHOLINE), 0.5-1.75 MG/ML OF TRIGLYCERIDES, 1.4-3.5 MG/ML OF FREE FATTY ACIDS, AND LESS THAN 1 MG/ML OF SP-C

PULMONARY SURFACTANT WHICH IS A NATURAL BOVINE LUNG EXTRACT CONTAINING PHOSPHOLIPIDS, NEUTRAL LIPIDS, FATTY ACIDS, AND SURFACTANT-ASSOCIATED PROTEINS (SP) TO WHICH COLFOSCERIL PALMITATE (DIPALMITOYLPHOSPHATIDYLCHOLINE), PALMITIC ACID, AND TRIPALMITIN ARE ADDED TO STANDARDIZE THE COMPOSITION AND TO MIMIC SURFACE-TENSION LOWERING PROPERTIES OF NATURAL LUNG SURFACTANT. THE RESULTING COMPOSITION PROVIDES 25 MG/ML OF PHOSPHOLIPIDS (INCLUDING 11.0-15.5 MG/ML OF DISATURATED PHOSPHATIDYLCHOLINE), 0.5-1.75 MG/ML OF TRIGLYCERIDES, 1.4-3.5 MG/ML OF FREE FATTY ACIDS, AND LESS THAN 1 MG/ML OF SP-C

SURFACTANT TA